BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, Kuipers EJ. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer. 2011;47:1211-1218. [PMID: 21239166 DOI: 10.1016/j.ejca.2010.12.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, Graham DY. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol 2011; 17(41): 4596-4601 [PMID: 22147965 DOI: 10.3748/wjg.v17.i41.4596] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
2 Liu D, Mehta D, Kaur S, Kumar A, Parikh K, Chawla L, Patel S, Devi A, Saha A. Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective. J Hematol Oncol 2018;11:138. [PMID: 30545376 DOI: 10.1186/s13045-018-0682-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
3 Kuipers EJ. Gastric Cancer: Synopsis and Epidemiology of Gastric Cancer. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 241-9. [DOI: 10.1007/978-981-287-706-2_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ding S, Blue RE, Chen Y, Scull B, Lund PK, Morgan D. Molecular Imaging of Gastric Neoplasia with Near-Infrared Fluorescent Activatable Probes. Mol Imaging 2012;11:7290.2012.00014. [DOI: 10.2310/7290.2012.00014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
5 Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology 2020;158:732-744.e16. [PMID: 31816301 DOI: 10.1053/j.gastro.2019.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
6 Chon I, Choi C, Shin CM, Park YS, Kim N, Lee DH. Effect of Helicobacter pylori eradication on subsequent dysplasia development after endoscopic resection of gastric dysplasia. Korean J Gastroenterol 2013;61:307-12. [PMID: 23877210 DOI: 10.4166/kjg.2013.61.6.307] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
7 Mera RM, Bravo LE, Camargo MC, Bravo JC, Delgado AG, Romero-Gallo J, Yepez MC, Realpe JL, Schneider BG, Morgan DR, Peek RM, Correa P, Wilson KT, Piazuelo MB. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2018;67:1239-1246. [PMID: 28647684 DOI: 10.1136/gutjnl-2016-311685] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 14.2] [Reference Citation Analysis]
8 Chapelle N, Péron M, Quénéhervé L, Bourget A, Leroy M, Touchefeu Y, Cauchin E, Coron E, Mosnier JF, Matysiak-Budnik T. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Clin Transl Gastroenterol 2020;11:e00237. [PMID: 33512802 DOI: 10.14309/ctg.0000000000000237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jiang JX, Liu Q, Zhao B, Zhang HH, Sang HM, Djaleel SM, Zhang GX, Xu SF. Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases. J Cancer Res Clin Oncol 2017;143:409-18. [PMID: 27832356 DOI: 10.1007/s00432-016-2299-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
10 Chojnacki C, Popławski T, Błońska A, Błasiak J, Romanowski M, Chojnacki J. Expression of tryptophan hydroxylase in gastric mucosa in symptomatic and asymptomatic Helicobacter pylori infection. Arch Med Sci 2019;15:416-23. [PMID: 30899295 DOI: 10.5114/aoms.2018.76928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Lin L, Yan L, Liu Y, Yuan F, Li H, Ni J. Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study. J Hematol Oncol 2019;12:96. [PMID: 31511035 DOI: 10.1186/s13045-019-0783-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 16.0] [Reference Citation Analysis]
12 Ebigbo A, Messmann H, Römmele C. Endoscopic Upper GI Screening. Visc Med 2019;35:240-4. [PMID: 31602385 DOI: 10.1159/000501889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 van der Post RS, van Dieren J, Grelack A, Hoogerbrugge N, van der Kolk LE, Snaebjornsson P, Lansdorp-Vogelaar I, van Krieken JH, Bisseling TM, Cats A. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. Gastrointest Endosc. 2018;87:397-404.e2. [PMID: 28455161 DOI: 10.1016/j.gie.2017.04.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
14 Ghosh S, Bankura B, Ghosh S, Saha ML, Pattanayak AK, Ghatak S, Guha M, Nachimuthu SK, Panda CK, Maji S, Chakraborty S, Maity B, Das M. Polymorphisms in ADH1B and ALDH2 genes associated with the increased risk of gastric cancer in West Bengal, India. BMC Cancer 2017;17:782. [PMID: 29166882 DOI: 10.1186/s12885-017-3713-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
15 Arieira C, Boal Carvalho P, Dias de Castro F, Cotter J. Esophagogastroduodenoscopy Findings in Patients on the Waiting List for Bariatric Surgery. GE Port J Gastroenterol 2019;26:389-95. [PMID: 31832493 DOI: 10.1159/000495770] [Reference Citation Analysis]
16 Burkitt MD, Duckworth CA, Williams JM, Pritchard DM. Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models. Dis Model Mech 2017;10:89-104. [PMID: 28151409 DOI: 10.1242/dmm.027649] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
17 van Blankenstein M, van Vuuren AJ, Looman CW, Ouwendijk M, Kuipers EJ. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol. 2013;48:794-800. [PMID: 23795659 DOI: 10.3109/00365521.2013.799221] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
18 Siregar GA, Parwati I, Achmad TH, Syukriani YF. Association between VEGF-634G>C Gene Polymorphism with Gastric Premalignant Lesions and Serum VEGF Levels in Helicobacter pylori Gastritis Patients. Open Access Maced J Med Sci 2018;6:1328-34. [PMID: 30159051 DOI: 10.3889/oamjms.2018.266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Wang HL, Zhou PY, Liu P, Zhang Y. ALDH2 and ADH1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis. PLoS One 2014;9:e88779. [PMID: 24633362 DOI: 10.1371/journal.pone.0088779] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
20 Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2016;65:563-574. [PMID: 25779597 DOI: 10.1136/gutjnl-2014-308588] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
21 Mansori K, Dehghanbanadaki H, Naderpour S, Rashti R, Moghaddam AB, Moradi Y. A systematic review and meta-analysis of the prevalence of Helicobacter pylori in patients with diabetes. Diabetes Metab Syndr 2020;14:601-7. [PMID: 32417710 DOI: 10.1016/j.dsx.2020.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Holster IL, Aarts MJ, Tjwa ET, Lemmens VE, Kuipers EJ. Trend breaks in incidence of non-cardia gastric cancer in the Netherlands. Cancer Epidemiol 2014;38:9-15. [PMID: 24309073 DOI: 10.1016/j.canep.2013.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
23 Huang RJ, Park S, Shen J, Longacre T, Ji H, Hwang JH. Pepsinogens and Gastrin Demonstrate Low Discrimination for Gastric Precancerous Lesions in a Multi-Ethnic United States Cohort. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00011-2. [PMID: 33434656 DOI: 10.1016/j.cgh.2021.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wang AY, Peura DA. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am. 2011;21:613-635. [PMID: 21944414 DOI: 10.1016/j.giec.2011.07.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
25 Leja M, Cine E, Rudzite D, Vilkoite I, Huttunen T, Daugule I, Rumba-Rozenfelde I, Pimanov S, Liepniece-Karele I, Pahomova J, Purmalis K, Eglitis J, Pirags V, Dzerve V, Erglis A. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Eur J Gastroenterol Hepatol 2012;24:1410-7. [PMID: 23114744 DOI: 10.1097/MEG.0b013e3283583ca5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
26 Abangah G, Rahmani A, Hafezi-Ahmadi MR, Emami T, Asadollahi K, Jaafari-Haidarlo A, Moradkhani A. Precancerous histopathologic lesions of upper gastrointestinal tract among dyspeptic patients upon endoscopic evaluations. J Gastrointest Cancer 2016;47:1-7. [PMID: 26454647 DOI: 10.1007/s12029-015-9760-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Huo X, Jia Y, Liu D, Gao L, Zhang L, Li L, Qi Y, Cao L. Photodynamic diagnosis of gastric cancer using HPPH-CD. RSC Adv 2016;6:39216-24. [DOI: 10.1039/c5ra27746a] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Chapelle N, Petryszyn P, Blin J, Leroy M, Le Berre-Scoul C, Jirka I, Neunlist M, Moussata D, Lamarque D, Olivier R, Tougeron D, Mosnier JF, Matysiak-Budnik T. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area. Helicobacter 2020;25:e12727. [PMID: 32700438 DOI: 10.1111/hel.12727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Xu Y, Miremadi A, Link A, Malfertheiner P, Fitzgerald RC, Bornschein J. Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study. J Clin Pathol 2019;72:825-9. [PMID: 31235543 DOI: 10.1136/jclinpath-2019-205700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Ebigbo A, Römmele C, Meisinger C, Probst A, Beyer A, Arnold J, Beer F, Endlicher E, Schiffelholz W, Linseisen J, Messmann H. [Screening gastroscopy in Germany - first results of the pilot phase of the Prä-GIT study]. Z Gastroenterol 2020;58:761-6. [PMID: 32572870 DOI: 10.1055/a-1190-5332] [Reference Citation Analysis]